STOCK TITAN

Axonics to Participate in September Investor Conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Axonics, Inc. to participate in investor conferences in September
Positive
  • None.
Negative
  • None.

IRVINE, Calif.--(BUSINESS WIRE)-- Axonics, Inc. (Nasdaq: AXNX), a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel dysfunction, is scheduled to participate in the following investor conferences in September:

Event: Wells Fargo Healthcare Conference
Date: Friday, September 8
Presentation time: 10:15 a.m. Eastern Time

Event: Morgan Stanley Healthcare Conference
Date: Monday, September 11
Presentation time: 10:00 a.m. Eastern Time

Event: Baird Healthcare Conference
Date: Tuesday, September 12
Presentation time: 3:10 p.m. Eastern Time

Event: CL King Best Ideas Conference
Date: Monday, September 18
Presentation time: 12:30 p.m. Eastern Time

Interested parties may access a live webcast and replay of each presentation by visiting the Axonics investor relations website.

About Axonics

Axonics is a global medical technology company that is developing and commercializing novel products for adults with bladder and bowel dysfunction. Axonics recently ranked No. 2 on the 2023 Financial Times ranking of the fastest growing companies in the Americas and No. 4 on the 2022 Deloitte Technology Fast 500.

Axonics® sacral neuromodulation systems provide adults with overactive bladder and/or fecal incontinence with long-lived, easy to use, safe, clinically effective therapy. In addition, the company’s best-in-class urethral bulking hydrogel, Bulkamid®, provides safe and durable symptom relief to women with stress urinary incontinence. In the U.S., moderate to severe urinary incontinence affects an estimated 28 million women and fecal incontinence affects an estimated 19 million adults. For more information, visit www.axonics.com.

Axonics contact:

Neil Bhalodkar

949-336-5293

IR@axonics.com

Source: Axonics, Inc.

Axonics, Inc.

NASDAQ:AXNX

AXNX Rankings

AXNX Latest News

AXNX Stock Data

3.43B
50.43M
1.07%
103.05%
6.74%
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
United States of America
IRVINE

About AXNX

axonics modulation technologies, inc is a privately-held medical device company developing an innovative neuromodulation platform based on a miniaturized rechargeable fully-implantable ipg licensed from the alfred mann foundation. the axonics sacral neuromodulation system is designed to improve the experience of both clinicians and patients suffering from urinary and fecal dysfunction.